Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

C Betriu

Showing results (11-20 of 38) with videos related to

Pageof 4
Sort By:
The Journal of Antimicrobial Chemotherapy|June 14, 2005
In vitro activity of tigecycline against Bacteroides speciesC Betriu, E Culebras, M Gómez, et al.
Enfermedades Infecciosas Y Microbiologia Clinica|June 1, 1989
[Bacteremia caused by Bacteroides. An analysis of 50 episodes]J Berenguer, J A Cuadros, C Betriu, et al.
Revista Clinica Espanola|February 1, 1988
[In vitro activity of 9 antimicrobials against Bacteroides fragilis]C Betriu Cabecerán, R Cogollos Agruña, G García Alonso, et al.
The Journal of Antimicrobial Chemotherapy|March 26, 2005
In vitro activity of tigecycline against ampicillin-resistant Haemophilus influenzae isolatesC Betriu, M Gómez, I Rodríguez-Avial, et al.
Antimicrobial Agents and Chemotherapy|April 1, 1990
Susceptibilities of species of the Bacteroides fragilis group to 10 antimicrobial agentsC Betriu, E Campos, C Cabronero, et al.
The Journal of Antimicrobial Chemotherapy|June 22, 2001
Antibiotic resistance surveillance of Stenotrophomonas maltophilia, 1993-1999C Betriu, A Sánchez, M L Palau, et al.
Journal of Clinical Microbiology|June 28, 2001
Endophthalmitis caused by Listeria monocytogenesC Betriu, S Fuentemilla, R Méndez, et al.
Antimicrobial Agents and Chemotherapy|July 14, 2001
In vitro activities of MK-0826 and 16 other antimicrobials against Bacteroides fragilis group strainsC Betriu, A Sánchez, M L Palau, et al.
Enfermedades Infecciosas Y Microbiologia Clinica|April 1, 1989
[Sensitivity to antimicrobials of group A Streptococcus]C Betriu, M C Cabronero, E Campos, et al.
Antimicrobial Agents and Chemotherapy|September 3, 1999
Activities of new antimicrobial agents (trovafloxacin, moxifloxacin, sanfetrinem, and quinupristin-dalfopristin) against Bacteroides fragilis group: comparison with the activities of 14 other agentsC Betriu, M Gómez, M L Palau, et al.
Pageof 4

Showing results (11-20 of 38) with videos related to

Sort By:
Pageof 4
The Journal of Antimicrobial Chemotherapy|June 14, 2005
In vitro activity of tigecycline against Bacteroides speciesC Betriu, E Culebras, M Gómez, et al.
Enfermedades Infecciosas Y Microbiologia Clinica|June 1, 1989
[Bacteremia caused by Bacteroides. An analysis of 50 episodes]J Berenguer, J A Cuadros, C Betriu, et al.
Revista Clinica Espanola|February 1, 1988
[In vitro activity of 9 antimicrobials against Bacteroides fragilis]C Betriu Cabecerán, R Cogollos Agruña, G García Alonso, et al.
The Journal of Antimicrobial Chemotherapy|March 26, 2005
In vitro activity of tigecycline against ampicillin-resistant Haemophilus influenzae isolatesC Betriu, M Gómez, I Rodríguez-Avial, et al.
Antimicrobial Agents and Chemotherapy|April 1, 1990
Susceptibilities of species of the Bacteroides fragilis group to 10 antimicrobial agentsC Betriu, E Campos, C Cabronero, et al.
The Journal of Antimicrobial Chemotherapy|June 22, 2001
Antibiotic resistance surveillance of Stenotrophomonas maltophilia, 1993-1999C Betriu, A Sánchez, M L Palau, et al.
Journal of Clinical Microbiology|June 28, 2001
Endophthalmitis caused by Listeria monocytogenesC Betriu, S Fuentemilla, R Méndez, et al.
Antimicrobial Agents and Chemotherapy|July 14, 2001
In vitro activities of MK-0826 and 16 other antimicrobials against Bacteroides fragilis group strainsC Betriu, A Sánchez, M L Palau, et al.
Enfermedades Infecciosas Y Microbiologia Clinica|April 1, 1989
[Sensitivity to antimicrobials of group A Streptococcus]C Betriu, M C Cabronero, E Campos, et al.
Antimicrobial Agents and Chemotherapy|September 3, 1999
Activities of new antimicrobial agents (trovafloxacin, moxifloxacin, sanfetrinem, and quinupristin-dalfopristin) against Bacteroides fragilis group: comparison with the activities of 14 other agentsC Betriu, M Gómez, M L Palau, et al.
Pageof 4